Informatie:
Fout:
ID
42889
Beschrijving
Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT00762671
Link
https://clinicaltrials.gov/show/NCT00762671
Trefwoorden
Versies (2)
- 13-08-16 13-08-16 -
- 17-09-21 17-09-21 -
Geüploaded op
17 september 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Type 1 Diabetes Mellitus NCT00762671
Eligibility Type 1 Diabetes Mellitus NCT00762671
- StudyEvent: Eligibility
Similar models
Eligibility Type 1 Diabetes Mellitus NCT00762671
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Dietry treatment, sulfonylureas, metformin or insulin
Item
subjects with diabetes mellitus will be eligible if they are receiving dietary treatment for hyperglycemia, sulfonylureas, metformin or insulin
boolean
C0012160 (UMLS CUI [1])
C3653359 (UMLS CUI [2])
C0025598 (UMLS CUI [3])
C0021641 (UMLS CUI [4])
C3653359 (UMLS CUI [2])
C0025598 (UMLS CUI [3])
C0021641 (UMLS CUI [4])
HbA1c
Item
any diabetic subject with a hgba1c level of <7% or >11%
boolean
C0019018 (UMLS CUI [1])
Atherosclerosis
Item
evidence of atherosclerosis
boolean
C0004153 (UMLS CUI [1])
Angina
Item
symptoms of angina
boolean
C0002962 (UMLS CUI [1])
Claudication
Item
symptoms of claudication
boolean
C1456822 (UMLS CUI [1])
Cerebrovascular ischemia
Item
symptoms of cerebrovascular ischemia
boolean
C0917798 (UMLS CUI [1])
Arterial occlusive disease
Item
findings of arterial occlusive disease, as would be suggested by decreased pulses, asymmetric blood pressure, bruits or reduced limb pressure measurements
boolean
C0003838 (UMLS CUI [1])
Systolic and diastolic blood pressure
Item
hypertension defined as a systolic blood pressure > = 150 mmhg and a diastolic blood pressure >= 95 mmhg; (allowable blood pressure medications for diabetic subjects include calcium channel blockers, alpha and beta adrenergic blockers, and diuretics)
boolean
C0871470 (UMLS CUI [1])
C0428883 (UMLS CUI [2])
C0428883 (UMLS CUI [2])
Total cholesterol and ldl cholesterol
Item
hypercholesterolemia, defined as total cholesterol levels greater than 75th percentile for age and sex and ldl cholesterol levels >130mg/dl.
boolean
C1445957 (UMLS CUI [1])
C0202117 (UMLS CUI [2])
C0202117 (UMLS CUI [2])
Serum creatinine
Item
renal insufficiency (serum creatinine >1.5 mg/dl for men; >1.2 mg/dl for women)
boolean
C0201976 (UMLS CUI [1])
Measurement of liver enzyme
Item
hepatic dysfunction defined as liver enzyme abnormalities > two times the upper limit of normal
boolean
C0428321 (UMLS CUI [1])
Chronic lung disease
Item
chronic pulmonary disease
boolean
C0746102 (UMLS CUI [1])
Congestive heart failure
Item
congestive heart failure
boolean
C0018802 (UMLS CUI [1])
Pregnancy
Item
pregnancy (or subjects planning to become pregnant);
boolean
C0032961 (UMLS CUI [1])
Smoking history
Item
history of cigarette smoking within the last five years;
boolean
C0543414 (UMLS CUI [1])
MI, stroke or unstable angina
Item
history of clinically significant coronary artery or cerebrovascular disease (defined as mi or stroke within 6 months, or presence of unstable angina)
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0002965 (UMLS CUI [3])
C0038454 (UMLS CUI [2])
C0002965 (UMLS CUI [3])
Vasoactive, cardioactive, or non-steroidal anti-inflammatory medications
Item
use of any, vasoactive, cardioactive, or non-steroidal anti-inflammatory medications within 24 hours of vascular testing visits
boolean
C0042397 (UMLS CUI [1,1])
C0007220 (UMLS CUI [1,2])
C0003211 (UMLS CUI [1,3])
C0007220 (UMLS CUI [1,2])
C0003211 (UMLS CUI [1,3])